Jennifer E. Snyder-Cappione
Boston University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jennifer E. Snyder-Cappione.
Proceedings of the National Academy of Sciences of the United States of America | 2013
Jason DeFuria; Anna C. Belkina; Madhumita Jagannathan-Bogdan; Jennifer E. Snyder-Cappione; Jordan Carr; Yanina R. Nersesova; Douglas Markham; Katherine J. Strissel; Amanda A. Watkins; Min Zhu; Jessica Allen; Jacqueline Bouchard; Gianluca Toraldo; Ravi Jasuja; Martin S. Obin; Marie E. McDonnell; Caroline M. Apovian; Gerald V. Denis; Barbara S. Nikolajczyk
Patients with type 2 diabetes (T2D) have disease-associated changes in B-cell function, but the role these changes play in disease pathogenesis is not well established. Data herein show B cells from obese mice produce a proinflammatory cytokine profile compared with B cells from lean mice. Complementary in vivo studies show that obese B cell–null mice have decreased systemic inflammation, inflammatory B- and T-cell cytokines, adipose tissue inflammation, and insulin resistance (IR) compared with obese WT mice. Reduced inflammation in obese/insulin resistant B cell–null mice associates with an increased percentage of anti-inflammatory regulatory T cells (Tregs). This increase contrasts with the sharply decreased percentage of Tregs in obese compared with lean WT mice and suggests that B cells may be critical regulators of T-cell functions previously shown to play important roles in IR. We demonstrate that B cells from T2D (but not non-T2D) subjects support proinflammatory T-cell function in obesity/T2D through contact-dependent mechanisms. In contrast, human monocytes increase proinflammatory T-cell cytokines in both T2D and non-T2D analyses. These data support the conclusion that B cells are critical regulators of inflammation in T2D due to their direct ability to promote proinflammatory T-cell function and secrete a proinflammatory cytokine profile. Thus, B cells are potential therapeutic targets for T2D.
AIDS | 2008
Lishomwa C. Ndhlovu; Joan M. Chapman; Aashish R. Jha; Jennifer E. Snyder-Cappione; Moraima Pagán; Fabio E. Leal; Brigid S Boland; Philip J. Norris; Michael G. Rosenberg; Douglas F. Nixon
IL-17 is proinflammatory cytokine secreted by a unique CD4+ T (Th17) cell subset and proposed to play a role in host defense. We hypothesized that Th17 cells are lost in HIV-1 infection. HIV-1-infected children with plasma viremia below 50 copies/ml had IL-17 production, whereas those with detectable viremia had minimal secretion. These results imply viral-mediated destruction or impairment of Th17 cells and argue for complete suppression of viremia for reconstitution of Th17 cells.
Blood | 2009
Jeffrey M. Milush; Brian R. Long; Jennifer E. Snyder-Cappione; Amedeo Cappione; Vanessa A. York; Lishomwa C. Ndhlovu; Lewis L. Lanier; Jakob Michaëlsson; Douglas F. Nixon
The lack of natural killer (NK) cell-specific markers, as well as the overlap among several common surface antigens and functional properties, has obscured the delineation between NK cells and dendritic cells. Here, novel subsets of peripheral blood CD3/14/19(neg) NK cells and monocyte/dendritic cell (DC)-like cells were identified on the basis of CD7 and CD4 expression. Coexpression of CD7 and CD56 differentiates NK cells from CD56+ monocyte/DC-like cells, which lack CD7. In contrast to CD7+CD56+ NK cells, CD7(neg)CD56+ cells lack expression of NK cell-associated markers, but share commonalities in their expression of various monocyte/DC-associated markers. Using CD7, we observed approximately 60% of CD4+CD56+ cells were CD7(neg) cells, indicating the actual frequency of activated CD4+ NK cells is much lower in the blood than previously recognized. Functionally, only CD7+ NK cells secrete gamma interferon (IFNgamma) and degranulate after interleukin-12 (IL-12) plus IL-18 or K562 target cell stimulation. Furthermore, using CD7 to separate CD56+ NK cells and CD56+ myeloid cells, we demonstrate that unlike resting CD7+CD56+ NK cells, the CD7(neg)CD56+ myeloid cells stimulate a potent allogeneic response. Our data indicate that CD7 and CD56 coexpression discriminates NK cells from CD7(neg)CD56+ monocyte/DC-like cells, thereby improving our ability to study the intricacies of NK-cell subset phenotypes and functions in vivo.
The Journal of Infectious Diseases | 2007
Jennifer E. Snyder-Cappione; Douglas F. Nixon; Christopher P. Loo; Joan M. Chapman; Duncan A. Meiklejohn; Fernando F. Melo; Priscilla R. Costa; Johan K. Sandberg; Denise S. Rodrigues; Esper G. Kallas
Mycobacterium tuberculosis (MTB) is a leading cause of mortality worldwide from an infectious agent. Natural killer T (NKT) cells recognize mycobacterial antigens and contribute to anti-MTB immunity in mouse models. NKT cells were measured in subjects with pulmonary tuberculosis, MTB-exposed individuals, and healthy controls. NKT cell levels are selectively lower in peripheral blood mononuclear cells from individuals with pulmonary tuberculosis than in both MTB-exposed subjects and healthy control subjects. This apparent loss of NKT cells from the peripheral blood is sustained during the 6 months after the initiation of MTB treatment. These findings indicate that NKT cells may be an important component of antituberculosis immunity.
AIDS | 2009
Jennifer E. Snyder-Cappione; Christopher P. Loo; Karina I. Carvalho; Carlotta Kuylenstierna; Steven G. Deeks; Frederick Hecht; Michael G. Rosenberg; Johan K. Sandberg; Esper G. Kallas; Douglas F. Nixon
Objective:Natural killer T (NKT) cells are efficiently targeted by HIV and severely reduced in numbers in the circulation of infected individuals. The functional capacity of the remaining NKT cells in HIV-infected individuals is poorly characterized. This study measured NKT cell cytokine production directly ex vivo and compared these responses with both the disease status and NKT subset distribution of individual patients. Methods:NKT cell frequencies, subsets, and ex-vivo effector functions were measured in the peripheral blood mononuclear cells of HIV-infected patients and healthy controls by flow cytometry. We measured cytokines from NKT cells after stimulation with either α-galactosyl ceramide-loaded CD1d dimers (DimerX-αGalCer) or phorbol myristate acetate and ionomycin. Results:The frequencies of NKT cells secreting interferon-γ and tumor necrosis factor-α were significantly lower in HIV-infected patients than healthy controls after DimerX-αGalCer treatment, but responses were similar after treatment with phorbol myristate acetate and ionomycin. The magnitude of the interferon-γ response to DimerX-αGalCer correlated inversely with the number of years of infection. Both interferon-γ and tumor necrosis factor-α production in response to DimerX-αGalCer correlated inversely with CD161 expression. Conclusion:The ex-vivo Th1 responses of circulating NKT cells to CD1d-glycolipid complexes are impaired in HIV-infected patients. NKT cell functions may be progressively lost over time in HIV infection, and CD161 is implicated in the regulation of NKT cell responsiveness.
PLOS ONE | 2010
Karina I. Carvalho; Karina Mescouto de Melo; Fernanda R. Bruno; Jennifer E. Snyder-Cappione; Douglas F. Nixon; Beatriz Tavares Costa-Carvalho; Esper G. Kallas
Common variable immunodeficiency disorder (CVID) is the commonest cause of primary antibody failure in adults and children, and characterized clinically by recurrent bacterial infections and autoimmune manifestations. Several innate immune defects have been described in CVID, but no study has yet investigated the frequency, phenotype or function of the key regulatory cell population, natural killer T (NKT) cells. We measured the frequencies and subsets of NKT cells in patients with CVID and compared these to healthy controls. Our results show a skewing of NKT cell subsets, with CD4+ NKT cells at higher frequencies, and CD8+ NKT cells at lower frequencies. However, these cells were highly activated and expression CD161. The NKT cells had a higher expression of CCR5 and concomitantly expression of CCR5+CD69+CXCR6 suggesting a compensation of the remaining population of NKT cells for rapid effector action.
Computer Methods and Programs in Biomedicine | 2008
Jonathan Rebhahn; Courtney Bishop; Anagha A. Divekar; Katty Jiminez-Garcia; James J. Kobie; F. Eun-Hyung Lee; Genny M. Maupin; Jennifer E. Snyder-Cappione; Dietmar M. W. Zaiss; Tim R. Mosmann
The Elispot effectively measures the frequencies of cells secreting particular molecules, especially low-frequency cells such as antigen-specific T cells. The Fluorospot assay adapted this analysis to two products per cell, and this has now been extended to three-color measurement of both mouse and human cytokine-secreting cells. Due to the increased data complexity, and particularly the need to define single-, double- and triple-producing cells, it is critical to objectively quantify spot number, size, intensity, and coincidence with other spots. An automated counting program, Exploraspot, was therefore developed to detect and quantify Fluorospots in automated fluorescence microscope images. Morphological parameters, including size, intensity, location, circularity and others are calculated for each spot, exported in FCS format, and further analyzed by gating and graphical display in popular flow cytometry analysis programs. The utility of Exploraspot is demonstrated by identification of single-, double- and triple-secreting T cells; tolerance of variable background fluorescence; and estimation of the numbers of genuine versus random multiple events.
Clinical and Experimental Immunology | 2009
Lishomwa C. Ndhlovu; Jennifer E. Snyder-Cappione; Karina I. Carvalho; Fabio E. Leal; Christopher P. Loo; Fernanda R. Bruno; Aashish R. Jha; D. Devita; Aaron M. Hasenkrug; H. M. R. Barbosa; Aluisio Cotrim Segurado; Douglas F. Nixon; E. L. Murphy; Esper G. Kallas
Human T lymphotropic virus type 1 (HTLV‐1) infects 10–20 million people worldwide. The majority of infected individuals are asymptomatic; however, approximately 3% develop the debilitating neurological disease HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is also currently no cure, vaccine or effective therapy for HTLV‐1 infection, and the mechanisms for progression to HAM/TSP remain unclear. NK T cells are an immunoregulatory T cell subset whose frequencies and effector functions are associated critically with immunity against infectious diseases. We hypothesized that NK T cells are associated with HAM/TSP progression. We measured NK T cell frequencies and absolute numbers in individuals with HAM/TSP infection from two cohorts on two continents: São Paulo, Brazil and San Francisco, CA, USA, and found significantly lower levels when compared with healthy subjects and/or asymptomatic carriers. Also, the circulating NK T cell compartment in HAM/TSP subjects is comprised of significantly more CD4+ and fewer CD8+ cells than healthy controls. These findings suggest that lower numbers of circulating NK T cells and enrichment of the CD4+ NK T subset are associated with HTLV‐1 disease progression.
European Journal of Immunology | 2013
Jennifer E. Snyder-Cappione; Douglas F. Nixon; Joyce C. Chi; Michelle-Linh T. Nguyen; Christopher K. Kirby; Jeffrey M. Milush; Laura L. Koth
Invariant natural killer T (iNKT) cells are integral components of immune responses during many chronic diseases, yet their surface phenotypes, subset distribution, and polyfunctional capacity in this environment are largely unknown. Therefore, using flow cytometry, we determined iNKT cell phenotypic and functional characteristics in subjects with chronic inflammatory disease sarcoidosis and matched controls. We found that sarcoidosis subjects displayed lower iNKT‐cell frequencies, which correlated with lung fibrosis, C‐reactive protein levels, and other measures of clinical disease. The CD4−CD8− (double negative, DN) iNKT‐cell population was selectively lower in diseased individuals and the remaining DN iNKT cells exhibited higher frequencies of the activation markers CD69 and CD56. Functionally, both total IFN‐γ+ and the dual‐functional IFN‐γ+ TNF‐α+ iNKT cells were decreased in sarcoidosis subjects and these functional defects correlated with total iNKT‐cell circulating frequencies. As the loss of polyfunctionality can reflect functional exhaustion, we measured the surface antigens programmed death‐1 receptor and CD57 and found that levels inversely correlated with dual‐functional iNKT‐cell percentages. These findings reveal that, similar to traditional T cells, iNKT cells may also undergo functional exhaustion, and that circulating iNKT‐cell frequencies reflect these defects. Programmed death‐1 receptor antagonists may therefore be attractive therapeutic candidates for sarcoidosis and other iNKT‐cell‐mediated chronic diseases.
Scandinavian Journal of Immunology | 2011
Carlotta Kuylenstierna; Jennifer E. Snyder-Cappione; Christopher P. Loo; Brian R. Long; Veronica D. Gonzalez; Jakob Michaëlsson; Markus Moll; Gerald Spotts; Frederick Hecht; Douglas F. Nixon; Johan K. Sandberg
Cytokine immunotherapy is being evaluated as adjunct treatment in infectious diseases. The effects on innate and adaptive immunity in vivo are insufficiently known. Here, we investigate whether combination treatment with antiretroviral therapy (ART) and Interleukin‐2 (IL‐2) of patients with primary HIV‐1 infection induces sustained increases in circulating NKT cell and NK cell numbers and effector functions and investigate how changes are coordinated in the two compartments. Patients with primary HIV‐1 infection starting ART were analyzed for numbers, phenotype and function of NKT cells, NK cells and dendritic cells (DC) in peripheral blood before, during and after IL‐2 treatment. NKT cells expanded during IL‐2 treatment as expected from previous studies. However, their response to α‐galactosyl ceramide antigen were retained but not boosted. Myeloid DC did not change their numbers or CD1d‐expression during treatment. In contrast, the NK cell compartment responded with rapid expansion of the CD56dim effector subset and enhanced IFNγ production. Expansions of NKT cells and NK cells retracted back towards baseline values at 12 months after IL‐2 treatment ended. In summary, NKT cells and NK cells respond to IL‐2 treatment with different kinetics. Effects on cellular function are distinct between the cell types and the effects appear not to be sustained after IL‐2 treatment ends. These results improve our understanding of the effects of cytokine immunotherapy on innate cellular immunity in early HIV‐1 infection.